{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:41:32Z","timestamp":1793032892868,"version":"4.5.0"},"reference-count":412,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["ZXKT17058"],"award-info":[{"award-number":["ZXKT17058"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC1702303"],"award-info":[{"award-number":["2017YFC1702303"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC1702104"],"award-info":[{"award-number":["2017YFC1702104"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011710","name":"Shaanxi Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2016SF-378"],"award-info":[{"award-number":["2016SF-378"]}],"id":[{"id":"10.13039\/501100011710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81830111"],"award-info":[{"award-number":["81830111"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81774201"],"award-info":[{"award-number":["81774201"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.pharmthera.2020.107698","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:33:39Z","timestamp":1602203619000},"page":"107698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["Current state and future perspective of cardiovascular medicines derived from natural products"],"prefix":"10.1016","volume":"216","author":[{"given":"Chunhui","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luoqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinli","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenjing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruili","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen L.","family":"Woodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng Xue","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2020.107698_bb9413","first-page":"269","article-title":"Overcoming Barriers to Development of Novel Therapies for Cardiovascular Disease","volume":"4","author":"Aarif","year":"2019","journal-title":"JACC: Basic to Translational Science."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0005","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3390\/nu11030627","article-title":"Leveraging the cardio-protective and anticancer properties of resveratrol in cardio-oncology","volume":"11","author":"Abdelgawad","year":"2019","journal-title":"Nutrients."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0010","series-title":"Molecular, clinical, and environmental toxicology","author":"Ag","year":"2009"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0015","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1165\/rcmb.2005-0289OC","article-title":"Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts","volume":"34","author":"Ali","year":"2006","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0020","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/bph.14577","article-title":"The citrus flavanone hesperetin preferentially inhibits slow-inactivating currents of a long QT syndrome type 3 syndrome Na(+) channel mutation","volume":"176","author":"Alvarez-Collazo","year":"2019","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0025","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2017.154","article-title":"Epidemiology of cardiovascular disease in young individuals","volume":"15","author":"Andersson","year":"2018","journal-title":"Nature Reviews. Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-020-0151-7","article-title":"Acute heart failure","volume":"6","author":"Arrigo","year":"2020","journal-title":"Nature Reviews. Disease Primers"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0035","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","article-title":"Discovery and resupply of pharmacologically active plant-derived natural products: A review","volume":"33","author":"Atanasov","year":"2015","journal-title":"Biotechnology Advances"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0040","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/01.CIR.53.2.364","article-title":"The acute hemodynamic effects of ethacrynic acid and furosemide in patients with chronic postcapillary pulmonary hypertension","volume":"53","author":"Austin","year":"1976","journal-title":"Circulation."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0045","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.addr.2016.04.010","article-title":"Biosynthesis of therapeutic natural products using synthetic biology","volume":"105","author":"Awan","year":"2016","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0050","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s40262-017-0543-3","article-title":"Clinical pharmacokinetics of Sacubitril\/Valsartan (LCZ696): A novel angiotensin receptor-neprilysin inhibitor","volume":"56","author":"Ayalasomayajula","year":"2017","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0055","first-page":"385","article-title":"Oleanolic acid prevents increase in blood pressure and nephrotoxicity in nitric oxide dependent type of hypertension in rats","volume":"7","author":"Bachhav","year":"2014","journal-title":"Pharmacognosy Ressearch"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0060","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/ptr.3431","article-title":"Oleanolic acid prevents glucocorticoid-induced hypertension in rats","volume":"25","author":"Bachhav","year":"2011","journal-title":"Phytotherapy Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0065","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0070","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3389\/fphar.2020.00687","article-title":"Sodium tanshinone II sulfonate A Ameliorates hypoxia-induced pulmonary hypertension","volume":"11","author":"Bao","year":"2020","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0075","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000174791","article-title":"Comparative effects of long-term therapy with captopril and ibopamine in chronic congestive heart failure in old patients","volume":"78","author":"Barabino","year":"1991","journal-title":"Cardiology."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0080","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1038\/s41598-020-61886-3","article-title":"Rhein, a novel Histone Deacetylase (HDAC) inhibitor with antifibrotic potency in human myocardial fibrosis","volume":"10","author":"Barbosa","year":"2020","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0085","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00330-007-0728-5","article-title":"Prediction of myocardial recovery by dobutamine magnetic resonance imaging and delayed enhancement early after reperfused acute myocardial infarction","volume":"18","author":"Barmeyer","year":"2008","journal-title":"European Radiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2217\/fca.15.80","article-title":"Improving cardiovascular protection: Focus on a cardiovascular polypill","volume":"12","author":"Barrios","year":"2016","journal-title":"Future Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0095","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1185\/0300799039117040","article-title":"Tolerability of percutaneous coronary interventions in patients receiving nadroparin calcium for unstable angina or non-Q-wave myocardial infarction: The Angiofrax study","volume":"19","author":"Bassand","year":"2003","journal-title":"Current Medical Research and Opinion"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0100","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1136\/hrt.2005.086959","article-title":"The pathophysiology of myocardial reperfusion: A pathologist's perspective","volume":"92","author":"Basso","year":"2006","journal-title":"Heart."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0110","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ejhf.1452","article-title":"Rationale and design of the DIGIT-HF trial (DIGitoxin to improve outcomes in patients with advanced chronic Heart Failure): A randomized, double-blind, placebo-controlled study","volume":"21","author":"Bavendiek","year":"2019","journal-title":"European Journal of Heart Failure"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2015.04.031","article-title":"Digoxin in patients with atrial fibrillation and heart failure: A meta-analysis","volume":"188","author":"Bavishi","year":"2015","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0120","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2165\/00003495-199040060-00003","article-title":"Antihypertensive medications and depression","volume":"40","author":"Beers","year":"1990","journal-title":"Drugs."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0125","doi-asserted-by":"crossref","first-page":"E56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: A report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrd3744","article-title":"Outlook for the next 5 years in drug innovation","volume":"11","author":"Berggren","year":"2012","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0135","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.scitotenv.2018.07.201","article-title":"Coffea canephora silverskin from different geographical origins: A comparative study","volume":"645","author":"Bessada","year":"2018","journal-title":"Science Total Environment"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0140","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1126\/science.85.2205.338","article-title":"Heparin and the formation of White Thrombi","volume":"85","author":"Best","year":"1937","journal-title":"Science."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0145","doi-asserted-by":"crossref","first-page":"E105","DOI":"10.1016\/S2352-3026(17)30014-5","article-title":"Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: The open-label, randomised, non-inferiority SURPRISE phase 3b trial","volume":"4","author":"Beyer-Westendorf","year":"2017","journal-title":"Lancet Haematology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0155","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0022-3565(25)26570-3","article-title":"Mechanism of cardiac arrhythmias and blood pressure changes induced in dogs by pentylenetetrazol, picrotoxin, and deslanoside","volume":"141","author":"Bircher","year":"1963","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0160","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-119-10-199311150-00002","article-title":"Coronary angiographic changes with lovastatin therapy. The monitored atherosclerosis regression Study (MARS)","volume":"119","author":"Blankenhorn","year":"1993","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0165","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/eci.12633","article-title":"Cellular recruitment in myocardial ischaemia\/reperfusion injury","volume":"46","author":"Bonaventura","year":"2016","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0170","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1517\/13543784.16.10.1541","article-title":"Novel cardiac myosin activators for acute heart failure","volume":"16","author":"Bragadeesh","year":"2007","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0175","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2165\/00003495-198836050-00003","article-title":"Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure","volume":"36","author":"Brogden","year":"1988","journal-title":"Drugs."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0180","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa011090","article-title":"Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease","volume":"345","author":"Brown","year":"2001","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0185","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0195-668X(03)00232-X","article-title":"The ajmaline challenge in Brugada syndrome: A useful tool or misleading information?","volume":"24","author":"Brugada","year":"2003","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0190","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/18715257113119990083","article-title":"Lappaconitine: Influence of halogen substituent on the antiarrhythmic activity","volume":"11","author":"Bryzgalov","year":"2013","journal-title":"Cardiovascular & Hematological Agents in Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0195","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/cvr\/cvz183","article-title":"New opportunities for targeting redox dysregulation in cardiovascular disease","volume":"116","author":"Bubb","year":"2020","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0200","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/07388551.2011.596804","article-title":"Rosmarinic acid and its derivatives: Biotechnology and applications","volume":"32","author":"Bulgakov","year":"2012","journal-title":"Critical Reviews in Biotechnology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0205","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1039\/b402985m","article-title":"Natural products to drugs: Natural product derived compounds in clinical trials","volume":"22","author":"Butler","year":"2005","journal-title":"Natural Product Reports"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0210","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1039\/b514294f","article-title":"Natural products to drugs: Natural product-derived compounds in clinical trials","volume":"25","author":"Butler","year":"2008","journal-title":"Natural Product Reports"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0215","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1039\/C4NP00064A","article-title":"Natural product and natural product derived drugs in clinical trials","volume":"31","author":"Butler","year":"2014","journal-title":"Natural Product Reports"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0220","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1177\/0300060519850401","article-title":"Combination therapy with beraprost sodium and aspirin for acute ischemic stroke: A single-center retrospective study","volume":"47","author":"Cai","year":"2019","journal-title":"The Journal of International Medical Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0225","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.toxicon.2011.07.013","article-title":"Bradykinin-potentiating peptides: Beyond captopril","volume":"59","author":"Camargo","year":"2012","journal-title":"Toxicon."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0230","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5694\/j.1326-5377.2003.tb05445.x","article-title":"Digoxin in heart failure and cardiac arrhythmias","volume":"179","author":"Campbell","year":"2003","journal-title":"The Medical Journal of Australia"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0235","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3892\/etm.2014.1540","article-title":"Chinese medicinal formula Guanxin Shutong capsule protects the heart against oxidative stress and apoptosis induced by ischemic myocardial injury in rats","volume":"7","author":"Cao","year":"2014","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0240","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41569-018-0049-1","article-title":"Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention","volume":"15","author":"Capodanno","year":"2018","journal-title":"Nature Reviews. Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0245","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.cardfail.2013.05.007","article-title":"Review of vasodilators in acute decompensated heart failure: The old and the new","volume":"19","author":"Carlson","year":"2013","journal-title":"Journal of Cardiac Failure"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0250","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jacc.2014.06.009","article-title":"A polypill strategy to improve global secondary cardiovascular prevention: From concept to reality","volume":"64","author":"Castellano","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0255","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nrcardio.2011.129","article-title":"Stable angina pectoris: Antianginal therapies and future directions","volume":"9","author":"Chaitman","year":"2011","journal-title":"Nature Reviews. Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0260","doi-asserted-by":"crossref","first-page":"E015983","DOI":"10.1136\/bmjopen-2017-015983","article-title":"Naoxuekang, Xinnaoshutong and Xuesaitong capsules for treating stroke: A protocol for a randomised controlled trial","volume":"7","author":"Chen","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0265","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1007\/s11064-013-1135-8","article-title":"Hydroxysafflor yellow A protects against cerebral ischemia-reperfusion injury by anti-apoptotic effect through PI3K\/Akt\/GSK3\u03b2 pathway in rat","volume":"38","author":"Chen","year":"2013","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0270","doi-asserted-by":"crossref","first-page":"18127","DOI":"10.1038\/s41598-019-54713-x","article-title":"Protective effects of Salidroside on cardiac function in mice with myocardial infarction","volume":"9","author":"Chen","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0275","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Cholesterol Treatment Trialists","year":"2012","journal-title":"Lancet."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0280","article-title":"Berberine: Metabolic and cardiovascular effects in preclinical and clinical trials","volume":"2009","author":"Cicero","year":"2009","journal-title":"Nutrition and Dietary Supplements"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0285","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/106002808602000301","article-title":"Enalapril: A new angiotensin converting enzyme inhibitor","volume":"20","author":"Cleary","year":"1986","journal-title":"Drug Intelligence & Clinical Pharmacy"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0290","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"Bmj."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0295","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.bbadis.2013.04.002","article-title":"Electrophysiological changes in heart failure and their implications for arrhythmogenesis","volume":"1832","author":"Coronel","year":"2013","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0300","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1038\/srep03698","article-title":"Producing aglycons of ginsenosides in bakers' yeast","volume":"4","author":"Dai","year":"2014","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0305","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2018.09.086","article-title":"Multitarget strategies to reduce myocardial ischemia\/reperfusion injury: JACC review topic of the week","volume":"73","author":"Davidson","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408398.2012.657921","article-title":"Cocoa and human health: From head to foot--a review","volume":"56","author":"De Araujo","year":"2016","journal-title":"Critical Reviews in Food Science and Nutrition"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0315","first-page":"950","article-title":"Update on low molecular weight heparins at the beginning of third millennium. Focus on reviparin","volume":"15","author":"Del Bono","year":"2011","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0320","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10735-013-9514-7","article-title":"Hesperetin protects against cardiac remodelling induced by pressure overload in mice","volume":"44","author":"Deng","year":"2013","journal-title":"Journal of Molecular Histology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0325","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1211\/jpp.60.1.0016","article-title":"(-)-Epigallocatechin gallate (EGCG) prevents isoprenaline-induced cardiac marker enzymes and membrane-bound ATPases","volume":"60","author":"Devika","year":"2008","journal-title":"The Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0330","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/CIRCRESAHA.115.306824","article-title":"Systems analysis of thrombus formation","volume":"118","author":"Diamond","year":"2016","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0335","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.7326\/0003-4819-39-6-1189","article-title":"Clinical evaluation of gitalin in the treatment of congestive heart failure","volume":"39","author":"Dimitroff","year":"1953","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0340","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jnutbio.2018.08.010","article-title":"Fisetin inhibits cardiac hypertrophy by suppressing oxidative stress","volume":"62","author":"Dong","year":"2018","journal-title":"The Journal of Nutritional Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0345","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1016\/j.jacc.2019.04.036","article-title":"Epidemiology of cardiovascular disease in China and opportunities for improvement: JACC International","volume":"73","author":"Du","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(93)90968-N","article-title":"Vasodilator effects of quercetin in isolated rat vascular smooth muscle","volume":"239","author":"Duarte","year":"1993","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0355","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2165\/00003495-199652020-00011","article-title":"Dalteparin sodium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders","volume":"52","author":"Dunn","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0360","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s11897-013-0150-z","article-title":"Heart failure and tachycardia-induced cardiomyopathy","volume":"10","author":"Ellis","year":"2013","journal-title":"Current Heart Failure Reports"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0365","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/nm.2507","article-title":"Ischemia and reperfusion--from mechanism to translation","volume":"17","author":"Eltzschig","year":"2011","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0370","first-page":"1","article-title":"Inhibition of platelet thrombus formation by dextran","volume":"109","author":"Evans","year":"1973","journal-title":"The Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0375","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/CIRCULATIONAHA.118.036044","article-title":"Dectin-1 contributes to myocardial ischemia\/reperfusion injury by regulating macrophage polarization and neutrophil infiltration","volume":"139","author":"Fan","year":"2019","journal-title":"Circulation."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0380","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00210-018-1556-7","article-title":"Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2\/STAT3 signaling pathway","volume":"391","author":"Fang","year":"2018","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0390","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jacc.2019.06.012","article-title":"Coronary artery disease and transcatheter aortic valve replacement: JACC state-of-the-art review","volume":"74","author":"Faroux","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0395","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF03020189","article-title":"Successful resuscitation of serious bupivacaine intoxication in a patient with pre-existing heart failure","volume":"50","author":"Favier","year":"2003","journal-title":"Canadian Journal of Anaesthesia"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0400","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1532-5415.1989.tb06828.x","article-title":"Reserpine for hypertension","volume":"37","author":"Feigenbaum","year":"1989","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0405","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1055\/s-0043-103415","article-title":"Kaempferol attenuates cardiac hypertrophy via regulation of ASK1\/MAPK signaling pathway and oxidative stress","volume":"83","author":"Feng","year":"2017","journal-title":"Planta Medica"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0410","first-page":"205","article-title":"A clinical analysis of 402 arrhythmia cases treated with Dauricine","volume":"4","author":"Feng","year":"1989","journal-title":"Journal of Clinical Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0415","first-page":"1575","article-title":"A breakthrough for out-of-hospital treatment of thrombosis","volume":"98","author":"Fern\u00e1ndez-Ruiz","year":"2017","journal-title":"Nature Reviews. Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0420","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1021\/ja01290a070","article-title":"Convallatoxin","volume":"59","author":"Fieser","year":"1937","journal-title":"Journal of the American Chemical Society"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0425","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/europace\/euaa012","article-title":"Diagnostic yield of hypertrophic cardiomyopathy in first-degree relatives of decedents with idiopathic left ventricular hypertrophy","volume":"22","author":"Finocchiaro","year":"2020","journal-title":"Europace."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0430","first-page":"346","article-title":"Differential regulation of thrombin activatable fibrinolytic inhibitor by low molecular weight heparins. Pharmacologic implications","volume":"23","author":"Florian-Kujawski","year":"2004","journal-title":"International Angiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0435","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jacc.2015.03.016","article-title":"Cardiovascular drug development: Is it dead or just hibernating?","volume":"65","author":"Fordyce","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0440","first-page":"217","article-title":"Effects of practolol in combination with terbutaline in the treatment of hypertension and arrhythmias in asthmatic patients","volume":"56","author":"Formgren","year":"1975","journal-title":"Scandinavian Journal of Respiratory Diseases"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0445","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1080\/14656566.2018.1532501","article-title":"Embracing the polypill as a cardiovascular therapeutic: Is this the best strategy?","volume":"19","author":"Franczyk","year":"2018","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0450","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/archinte.1984.00350190137023","article-title":"Review of the overall experience of captopril in hypertension","volume":"144","author":"Frohlich","year":"1984","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0455","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/eurheartj\/eht090","article-title":"Myocardial reperfusion injury: looking beyond primary PCI","volume":"34","author":"Fr\u00f6hlich","year":"2013","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0460","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1159\/000495677","article-title":"Notoginsenoside R1 protects HUVEC against oxidized low density lipoprotein (Ox-LDL)-Induced atherogenic response via down-regulating miR-132","volume":"51","author":"Fu","year":"2018","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0465","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejphar.2007.04.031","article-title":"Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis","volume":"568","author":"Fu","year":"2007","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0470","doi-asserted-by":"crossref","first-page":"E112741","DOI":"10.1371\/journal.pone.0112741","article-title":"Inhibition of platelet activation and thrombus formation by adenosine and inosine: Studies on their relative contribution and molecular modeling","volume":"9","author":"Fuentes","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0475","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJMra0801082","article-title":"Mechanisms of thrombus formation","volume":"359","author":"Furie","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0480","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12890-015-0164-2","article-title":"Survival with sildenafil and inhaled iloprost in a cohort with pulmonary hypertension: An observational study","volume":"16","author":"Gall","year":"2016","journal-title":"BMC Pulmonary Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0485","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3390\/molecules24020340","article-title":"Plant-derived oleanolic acid (OA) ameliorates risk factors of cardiovascular diseases in a diet-induced pre-diabetic rat model: Effects on selected cardiovascular risk factors","volume":"24","author":"Gamede","year":"2019","journal-title":"Molecules."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2017.12.003","article-title":"Anti-hypertensive drugs and skin cancer risk: A review of the literature and meta-analysis","volume":"122","author":"Gandini","year":"2018","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0495","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41557-020-0467-7","article-title":"FAD-dependent enzyme-catalysed intermolecular [4+2] cycloaddition in natural product biosynthesis","volume":"12","author":"Gao","year":"2020","journal-title":"Nature Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0500","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.autneu.2006.03.009","article-title":"Effect of postnatal exposure to caffeine on the pattern of adenosine A1 receptor distribution in respiration-related nuclei of the rat brainstem","volume":"126-127","author":"Gaytan","year":"2006","journal-title":"Autonomic Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0505","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0002-8703(75)90252-5","article-title":"Quinidine plasma concentration and exertional arrhythmia","volume":"90","author":"Gey","year":"1975","journal-title":"American Heart Journal"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0510","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pharmthera.2016.03.008","article-title":"Pharmacological approaches of refractory angina","volume":"163","author":"Giannopoulos","year":"2016","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0515","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00019053-199711010-00010","article-title":"Simvastatin. A reappraisal of its cost effectiveness in dyslipidaemia and coronary heart disease","volume":"11","author":"Goa","year":"1996","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0520","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJM195703212561202","article-title":"Acetyldigitoxin in the treatment of heart failure","volume":"256","author":"Gold","year":"1957","journal-title":"The New England Journal of Medicine"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2020.107698_bb0525","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/00005344-199000153-00006","article-title":"Enalapril: Benefit-to-risk ratio in hypertensive patients","volume":"15","author":"Gomez","year":"1990","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0530","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jacc.2015.08.038","article-title":"Arrhythmia-Induced cardiomyopathies: Mechanisms, recognition, and management","volume":"66","author":"Gopinathannair","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0535","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2460\/ajvr.76.2.116","article-title":"Cardiovascular effects of dopamine hydrochloride and phenylephrine hydrochloride in healthy isoflurane-anesthetized New Zealand White rabbits (Oryctolagus cuniculus)","volume":"76","author":"Gosliga","year":"2015","journal-title":"American Journal of Veterinary Research"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2020.107698_bb0540","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1007\/s10072-008-0882-9","article-title":"Essential hypertension and the sympathetic nervous system","volume":"29","author":"Grassi","year":"2008","journal-title":"Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0545","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","author":"Group","year":"1997","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0550","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.53738\/REVMED.2005.1.32.2093","article-title":"Cutaneous complications of anti-hypertensive drugs","volume":"1","author":"Gr\u00fcnenwald","year":"2005","journal-title":"Revue M\u00e9dicale Suisse"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0555","doi-asserted-by":"crossref","first-page":"12108","DOI":"10.1073\/pnas.1218061110","article-title":"CYP76AH1 catalyzes turnover of miltiradiene in tanshinones biosynthesis and enables heterologous production of ferruginol in yeasts","volume":"110","author":"Guo","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0560","doi-asserted-by":"crossref","first-page":"E20271","DOI":"10.1097\/MD.0000000000020271","article-title":"A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome)","volume":"99","author":"Guo","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0565","doi-asserted-by":"crossref","first-page":"104883","DOI":"10.1016\/j.phrs.2020.104883","article-title":"Xinyue Capsule in patients with stable coronary artery disease after percutaneous coronary intervention: a multicenter, randomized, placebo-controlled trial","volume":"158","author":"Guo","year":"2020","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0570","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s13063-016-1531-x","article-title":"Effect of Xinyue capsules on patients with coronary heart disease after percutaneous coronary intervention: Study protocol for a randomized controlled trial","volume":"17","author":"Guo","year":"2016","journal-title":"Trials."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0575","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.hjc.2017.11.011","article-title":"Tanshinone modulates the expression of Bcl-2 and Bax in cardiomyocytes and has a protective effect in a rat model of myocardial ischemia-reperfusion","volume":"59","author":"Guo","year":"2018","journal-title":"Hellenic Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0580","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.phymed.2018.01.019","article-title":"Identifying potential quality markers of Xin-Su-Ning capsules acting on arrhythmia by integrating UHPLC-LTQ-Orbitrap, ADME prediction and network target analysis","volume":"44","author":"Guo","year":"2018","journal-title":"Phytomedicine."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0585","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1161\/CIRCULATIONAHA.115.018580","article-title":"Long-term effectiveness and safety of pravastatin in patients with coronary heart disease: Sixteen years of follow-up of the LIPID Study","volume":"133","author":"Hague","year":"2016","journal-title":"Circulation."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0590","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1159\/000487871","article-title":"Qiliqiangxin Attenuates cardiac remodeling via inhibition of TGF-\u03b21\/Smad3 and NF-\u03baB signaling pathways in a rat model of myocardial infarction","volume":"45","author":"Han","year":"2018","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0595","doi-asserted-by":"crossref","first-page":"35319","DOI":"10.1038\/srep35319","article-title":"Hydroxysafflor yellow A alleviates myocardial ischemia\/reperfusion in hyperlipidemic animals through the suppression of TLR4 signaling","volume":"6","author":"Han","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0600","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3389\/fphar.2017.00456","article-title":"Rosmarinic acid protects against inflammation and cardiomyocyte apoptosis during myocardial ischemia\/reperfusion injury by activating peroxisome proliferator-activated receptor gamma","volume":"8","author":"Han","year":"2017","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0605","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s40256-018-00317-1","article-title":"Drug treatment of hyperlipidemia in Chinese Patients: Focus on the use of simvastatin and ezetimibe alone and in combination","volume":"19","author":"Han","year":"2019","journal-title":"American Journal of Cardiovascular Drugs"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0610","first-page":"S112","article-title":"Coenzyme Q10 and coronary artery disease","volume":"71","author":"Hanaki","year":"1993","journal-title":"The Clinical Investigator"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0615","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/jac\/dkz076","article-title":"A population pharmacokinetic study of benzathine benzylpenicillin G administration in children and adolescents with rheumatic heart disease: New insights for improved secondary prophylaxis strategies","volume":"74","author":"Hand","year":"2019","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0620","doi-asserted-by":"crossref","first-page":"104306","DOI":"10.1016\/j.phrs.2019.104306","article-title":"Ethanol extracts of Danlou tablet attenuate atherosclerosis via inhibiting inflammation and promoting lipid effluent","volume":"146","author":"Hao","year":"2019","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0625","doi-asserted-by":"crossref","first-page":"603","DOI":"10.5530\/ijper.51.4.90","article-title":"An evaluation of antioxidant potential of flavonoid eriodictyol in isoproterenol-induced myocardial infarction in rats","volume":"51","author":"Hariharan","year":"2017","journal-title":"Indian Journal of Pharmaceutical Education and Research."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0630","first-page":"57","article-title":"Prophylaxis of deep-vein thrombosis after total hip replacement. Dextran and external pneumatic compression compared with 1.2 or 0.3 gram of aspirin daily","volume":"67","author":"Harris","year":"1985","journal-title":"The Journal of Bone and Joint Surgery. American Volume"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0635","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0753-3322(89)90133-9","article-title":"Aspirin and prevention of myocardial infarction","volume":"43","author":"Hartney","year":"1989","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0640","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia-reperfusion injury: A neglected therapeutic target","volume":"123","author":"Hausenloy","year":"2013","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0645","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/s13063-018-2908-9","article-title":"Xue-Fu-Zhu-Yu capsule in the treatment of qi stagnation and blood stasis syndrome: A study protocol for a randomised controlled pilot and feasibility trial","volume":"19","author":"He","year":"2018","journal-title":"Trials."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0650","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/FJC.0b013e3182893fd5","article-title":"Effects of salvianolic acid A on plasma and tissue dimethylarginine levels in a rat model of myocardial infarction","volume":"61","author":"He","year":"2013","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0655","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1039\/C6NP00024J","article-title":"Modern mass spectrometry for synthetic biology and structure-based discovery of natural products","volume":"33","author":"Henke","year":"2016","journal-title":"Natural Product Reports"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0660","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00000441-195605000-00007","article-title":"The response to rescinnamine administered parenterally and orally for the treatment of hypertension","volume":"231","author":"Hershberger","year":"1956","journal-title":"The American Journal of the Medical Sciences"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0665","author":"Heusch"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0670","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/ptr.2452","article-title":"Cardioprotective effects and underlying mechanisms of oxymatrine against Ischemic myocardial injuries of rats","volume":"22","author":"Hong-Li","year":"2008","journal-title":"Phytotherapy Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0675","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1745-6215-14-138","article-title":"Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: Study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF)","volume":"14","author":"Hou","year":"2013","journal-title":"Trials."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0680","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1073\/pnas.0813280106","article-title":"Long-term efficacy and safety of all-trans retinoic acid\/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia","volume":"106","author":"Hu","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0685","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3892\/ijmm.2016.2584","article-title":"Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt\/Nrf2\/HO-1 pathway","volume":"38","author":"Hu","year":"2016","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0690","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s10753-015-0242-x","article-title":"Icariin Attenuates High-cholesterol diet induced atherosclerosis in rats by inhibition of inflammatory response and p38 MAPK signaling pathway","volume":"39","author":"Hu","year":"2016","journal-title":"Inflammation."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0695","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nature Protocols"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0700","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201800955","article-title":"Isoquercitrin attenuated cardiac dysfunction Via AMPK\u03b1-dependent pathways in LPS-treated mice","volume":"62","author":"Huang","year":"2018","journal-title":"Molecular Nutrition & Food Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0705","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1042\/BST20160063","article-title":"New chemistry from natural product biosynthesis","volume":"44","author":"Hubert","year":"2016","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0710","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(17)30553-6","article-title":"Uses of polypills for cardiovascular disease and evidence to date","volume":"389","author":"Huffman","year":"2017","journal-title":"Lancet."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0715","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.jacc.2015.02.032","article-title":"Evolving therapies for myocardial ischemia\/reperfusion injury","volume":"65","author":"Ib\u00e1\u00f1ez","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0720","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0002-8703(96)90005-8","article-title":"Attenuation of the no-reflow phenomenon after coronary angioplasty for acute myocardial infarction with intracoronary papaverine","volume":"132","author":"Ishihara","year":"1996","journal-title":"American Heart Journal"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0725","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1111\/bph.15054","article-title":"A practical guide for transparent reporting of research on natural products in the British Journal of Pharmacology: Reproducibility of natural product research","volume":"177","author":"Izzo","year":"2020","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0730","first-page":"18","article-title":"Mineralocorticoid receptor antagonists in elderly patients with heart failure: A systematic review and meta-analysis","volume":"46","author":"Japp","year":"2017","journal-title":"Age and Ageing"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0735","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/10715762.2017.1390227","article-title":"The cardioprotective effect of rosmarinic acid on acute myocardial infarction and genes involved in Ca(2+) homeostasis","volume":"51","author":"Javidanpour","year":"2017","journal-title":"Free Radical Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0740","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.biopha.2018.03.103","article-title":"The inhibitory effect of rosmarinic acid on overexpression of NCX1 and stretch- induced arrhythmias after acute myocardial infarction in rats","volume":"102","author":"Javidanpour","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0745","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.3390\/molecules20022425","article-title":"A review of odd-chain fatty acid metabolism and the role of pentadecanoic Acid (c15:0) and heptadecanoic Acid (c17:0) in health and disease","volume":"20","author":"Jenkins","year":"2015","journal-title":"Molecules."},{"issue":"19","key":"10.1016\/j.pharmthera.2020.107698_bb9410","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2010.06.034","article-title":"Combination of loop diuretics with thiazide-type diuretics in heart failure","volume":"56","author":"Jentzer","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0750","first-page":"573","article-title":"Milestones of cardiovascular therapy. IV. Reserpine","volume":"146","author":"Jerie","year":"2007","journal-title":"Casop\u00eds L\u00e9kar\u0306\u016f C\u0306esk\u00fdch"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0755","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10557-020-06965-3","article-title":"Effects of Xuezhitong in patients with hypertriglyceridemia: A multicentre, randomized, double-blind, double simulation. Positive drug and placebo parallel control study","volume":"34","author":"Jia","year":"2020","journal-title":"Cardiovascular Drugs and Therapy"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0760","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jep.2011.09.049","article-title":"Biomarkers in the early period of acute myocardial infarction in rat serum and protective effects of Shexiang Baoxin Pill using a metabolomic method","volume":"138","author":"Jiang","year":"2011","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0765","doi-asserted-by":"crossref","first-page":"E105368","DOI":"10.1371\/journal.pone.0105368","article-title":"Metabolic engineering of Saccharomyces cerevisiae for caffeine and theobromine production","volume":"9","author":"Jin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0770","doi-asserted-by":"crossref","first-page":"F4726","DOI":"10.1136\/bmj.f4726","article-title":"Novel drugs for treating angina","volume":"347","author":"Jones","year":"2013","journal-title":"BMJ."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0775","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.jacc.2016.07.781","article-title":"The changing landscape of randomized clinical trials in cardiovascular disease","volume":"68","author":"Jones","year":"2016","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0780","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCRESAHA.117.308903","article-title":"Reducing the global burden of cardiovascular disease, Part 1: The epidemiology and risk factors","volume":"121","author":"Joseph","year":"2017","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0785","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jacc.2019.04.067","article-title":"The evolution of \u03b2-blockers in coronary artery disease and heart failure (Part 1\/5)","volume":"74","author":"Joseph","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0790","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/jama.2019.19026","article-title":"Cardiovascular disease prevention at a crossroads: Precision medicine or polypill?","volume":"322","author":"Joyner","year":"2019","journal-title":"JAMA."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0795","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3389\/fphar.2017.00560","article-title":"Inhibition of collagen-induced platelet aggregation by the secobutanolide secolincomolide a from lindera obtusiloba blume","volume":"8","author":"Jung","year":"2017","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0800","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-74-1-1","article-title":"Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study","volume":"74","author":"Kannel","year":"1971","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0805","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0272-6386(12)80586-5","article-title":"The effects of lovastatin in hyperlipidemic patients with the nephrotic syndrome","volume":"15","author":"Kasiske","year":"1990","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0810","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2125.1990.tb03802.x","article-title":"Single-dose effects of ibopamine hydrochloride on renal function in patients with congestive heart failure","volume":"30","author":"Kasmer","year":"1990","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0815","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10295-015-1723-5","article-title":"Natural product discovery: Past, present, and future","volume":"43","author":"Katz","year":"2016","journal-title":"Journal of Industrial Microbiology & Biotechnology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0820","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pharmthera.2008.03.009","article-title":"The low-affinity site of the beta1-adrenoceptor and its relevance to cardiovascular pharmacology","volume":"118","author":"Kaumann","year":"2008","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0825","first-page":"269","article-title":"Overcoming barriers to development of novel therapies for cardiovascular disease: Insights from the oncology drug development experience","volume":"4","author":"Khakoo","year":"2019","journal-title":"JACC: Basic to Translational Science"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0830","first-page":"269","article-title":"Overcoming barriers to development of novel therapies for cardiovascular disease","volume":"4","author":"Khakoo","year":"2019","journal-title":"JACC: Basic to Translational Science"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0835","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/nu11010039","article-title":"Tea polyphenols in promotion of human health","volume":"11","author":"Khan","year":"2018","journal-title":"Nutrients."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0840","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jacc.2019.05.045","article-title":"Clonal hematopoiesis of indeterminate potential reshapes age-related CVD: JACC review topic of the week","volume":"74","author":"Khetarpal","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0845","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.phrs.2003.09.012","article-title":"Pharmacokinetics and a simulation model of colforsin daropate, new forskolin derivative inotropic vasodilator, in patients undergoing coronary artery bypass grafting","volume":"49","author":"Kikura","year":"2004","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0850","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1378\/chest.42.2.170","article-title":"A combination of methyclothiazide and deserpidine in the treatment of essential hypertension","volume":"42","author":"Kossover","year":"1962","journal-title":"Diseases of the Chest"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0855","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028649","article-title":"Biobanking for discovery of novel cardiovascular biomarkers using imaging-quantified disease burden: Protocol for the longitudinal, prospective, BioHEART-CT cohort study","volume":"9","author":"Kott","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0860","first-page":"785","article-title":"Thrombosis and platelets: An update","volume":"38","author":"Koupenova","year":"2017","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0865","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1476-5381.1990.tb14648.x","article-title":"Comparison of the effects of xamoterol and isoprenaline on rat cardiac beta-adrenoceptors: Studies of function and regulation","volume":"99","author":"Kowalski","year":"1990","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0870","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s00380-018-1136-2","article-title":"Comparison of the effects of linagliptin and voglibose on endothelial function in patients with type 2 diabetes and coronary artery disease: A prospective, randomized, pilot study (EFFORT)","volume":"33","author":"Koyama","year":"2018","journal-title":"Heart and Vessels"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0875","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/molecules24061076","article-title":"Isoflavones","volume":"24","author":"Krizova","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0880","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1440-1681.1985.tb02314.x","article-title":"Cardiovascular effects of brovincamine and possible mechanisms involved","volume":"12","author":"Kushiku","year":"1985","journal-title":"Clinical and Experimental Pharmacology & Physiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0885","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijcard.2014.11.176","article-title":"Comparison of a morning polypill, evening polypill and individual pills on LDL-cholesterol, ambulatory blood pressure and adherence in high-risk patients; A randomized crossover trial","volume":"181","author":"Lafeber","year":"2015","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0890","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1177\/1741826711428066","article-title":"The cardiovascular polypill in high-risk patients","volume":"19","author":"Lafeber","year":"2012","journal-title":"European Journal of Preventive Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0895","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/2047487317695616","article-title":"Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk","volume":"24","author":"Lafeber","year":"2017","journal-title":"European Journal of Preventive Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0900","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1177\/2047487315624523","article-title":"Estimated cardiovascular relative risk reduction from fixed-dose combination pill (polypill) treatment in a wide range of patients with a moderate risk of cardiovascular disease","volume":"23","author":"Lafeber","year":"2016","journal-title":"European Journal of Preventive Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0905","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001814","article-title":"Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 2: Clinical studies","volume":"2","author":"Lanzani","year":"2010","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0910","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMoa011327","article-title":"Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization","volume":"347","author":"Lassen","year":"2002","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb9414","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/CIRCRESAHA.118.313161","article-title":"Omics, Big Data, and Precision Medicine in Cardiovascular Sciences","volume":"122","author":"Lau","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0915","doi-asserted-by":"crossref","first-page":"14526","DOI":"10.3390\/ijms160714526","article-title":"Eriodictyol protects endothelial cells against oxidative stress-induced cell death through modulating ERK\/Nrf2\/ARE-dependent heme oxygenase-1 Expression","volume":"16","author":"Lee","year":"2015","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0920","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1016-8478(23)13772-1","article-title":"Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing I(kappa)B kinase-dependent NF-kappaB activation","volume":"16","author":"Lee","year":"2003","journal-title":"Molecules and Cells"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0925","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ancard.2016.10.011","article-title":"Hypertension and coronary artery disease: New concept?","volume":"66","author":"Lef\u00e8vre","year":"2017","journal-title":"Ann Cardiology Angeiol (Paris)"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0930","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jcp.25483","article-title":"The \u03b22-adrenoceptor agonist terbutaline stimulates angiogenesis via Akt and ERK signaling","volume":"232","author":"Lemmens","year":"2017","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0935","doi-asserted-by":"crossref","first-page":"E104255","DOI":"10.1371\/journal.pone.0104255","article-title":"Qishenyiqi protects ligation-induced left ventricular remodeling by attenuating inflammation and fibrosis via STAT3 and NF-\u03baB signaling pathway","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0940","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/pharmaceutics11060281","article-title":"Epoprostenol delivered via high flow nasal cannula for ICU subjects with severe hypoxemia comorbid with pulmonary hypertension or right heart dysfunction","volume":"11","author":"Li","year":"2019","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0945","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/0091270009337509","article-title":"Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)","volume":"49","author":"Li","year":"2009","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0950","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/07853891003652534","article-title":"Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)","volume":"42","author":"Li","year":"2010","journal-title":"Annals of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0955","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.phymed.2018.03.002","article-title":"Identification of quality markers of Yuanhu Zhitong tablets based on integrative pharmacology and data mining","volume":"44","author":"Li","year":"2018","journal-title":"Phytomedicine."},{"key":"10.1016\/j.pharmthera.2020.107698_bb0960","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biopha.2016.09.014","article-title":"Tanshinone IIA protects against myocardial ischemia reperfusion injury by activating the PI3K\/Akt\/mTOR signaling pathway","volume":"84","author":"Li","year":"2016","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0965","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/j.athoracsur.2005.12.065","article-title":"Pravastatin improves remodeling and cardiac function after myocardial infarction by an antiinflammatory mechanism rather than by the induction of angiogenesis","volume":"81","author":"Li","year":"2006","journal-title":"The Annals of Thoracic Surgery"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0970","article-title":"Two case reports of neonatal autoantibody-associated congenital heart block","volume":"97","author":"Li","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0975","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jacc.2013.05.035","article-title":"A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure","volume":"62","author":"Li","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0980","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12906-019-2778-z","article-title":"Efficacy and safety of oral Guanxinshutong capsules in patients with stable angina pectoris in China: a prospective, multicenter, double-blind, placebo-controlled, randomized clinical trial","volume":"19","author":"Li","year":"2019","journal-title":"BMC Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0985","doi-asserted-by":"crossref","first-page":"108817","DOI":"10.1016\/j.biopha.2019.108817","article-title":"Xuezhikang improves the outcomes of cardiopulmonary resuscitation in rats by suppressing the inflammation response through TLR4\/NF-\u03baB pathway","volume":"114","author":"Liang","year":"2019","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2020.107698_bb0990","doi-asserted-by":"crossref","first-page":"104846","DOI":"10.1016\/j.phrs.2020.104846","article-title":"Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission","volume":"157","author":"Liang","year":"2020","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1000","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3892\/ijmm.2017.2949","article-title":"Allicin induces the upregulation of ABCA1 expression via PPAR\u03b3\/LXR\u03b1 signaling in THP-1 macrophage-derived foam cells","volume":"39","author":"Lin","year":"2017","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1005","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jacc.2016.11.078","article-title":"Herbal medications in cardiovascular medicine","volume":"69","author":"Liperoti","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/10286020.2012.723203","article-title":"Fructus Gardenia (Gardenia jasminoides J. Ellis) phytochemistry, pharmacology of cardiovascular, and safety with the perspective of new drugs development","volume":"15","author":"Liu","year":"2013","journal-title":"Journal of Asian Natural Products Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1015","doi-asserted-by":"crossref","first-page":"110283","DOI":"10.1016\/j.biopha.2020.110283","article-title":"Dual-screening of anti-inflammatory and antioxidant active ingredients of shenxiang suhe pill and its potential multi-target therapy for coronary heart disease","volume":"129","author":"Liu","year":"2020","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1020","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s10753-016-0374-7","article-title":"Geraniin Inhibits LPS-Induced THP-1 macrophages switching to M1 phenotype via SOCS1\/NF-\u03baB pathway","volume":"39","author":"Liu","year":"2016","journal-title":"Inflammation."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1025","doi-asserted-by":"crossref","first-page":"605714","DOI":"10.1155\/2014\/605714","article-title":"Chinese medicine shensongyangxin is effective for patients with bradycardia: Results of a randomized, double-blind, placebo-controlled multicenter trial","volume":"2014","author":"Liu","year":"2014","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2014.03.032","article-title":"The effect of homocysteine-lowering therapy with folic acid on flow-mediated vasodilation in patients with coronary artery disease: A meta-analysis of randomized controlled trials","volume":"235","author":"Liu","year":"2014","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1040","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejphar.2006.04.023","article-title":"Ligustilide inhibits vascular smooth muscle cells proliferation","volume":"542","author":"Lu","year":"2006","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1045","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/CIRCRESAHA.117.311311","article-title":"RNA therapeutics in cardiovascular disease","volume":"123","author":"Lucas","year":"2018","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1050","first-page":"151","article-title":"Enhanced angiogenesis and astrocyte activation by ecdysterone treatment in a focal cerebral ischemia rat model","volume":"110","author":"Luo","year":"2011","journal-title":"Acta Neurochirurgica. Supplement"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1055","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis","volume":"21","author":"Luo","year":"2020","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145130","article-title":"Tongxinluo protects against hypertensive kidney injury in spontaneously-hypertensive rats by inhibiting oxidative stress and activating forkhead box O1 signaling","volume":"10","author":"Luo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1065","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.copbio.2014.09.002","article-title":"Recent advances in natural product discovery","volume":"30","author":"Luo","year":"2014","journal-title":"Current Opinion in Biotechnology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1070","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1039\/C5CS00025D","article-title":"Engineered biosynthesis of natural products in heterologous hosts","volume":"44","author":"Luo","year":"2015","journal-title":"Chemical Society Reviews"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1075","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1111\/1750-3841.14936","article-title":"Ligustilide inhibited rat vascular smooth muscle cells migration via c-Myc\/MMP2 and ROCK\/JNK signaling pathway","volume":"84","author":"Luo","year":"2019","journal-title":"Journal of Food Science"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1080","first-page":"506","article-title":"Rutin inhibits coronary heart disease through ERK1\/2 and Akt signaling in a porcine model","volume":"15","author":"Lv","year":"2018","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1085","doi-asserted-by":"crossref","first-page":"108639","DOI":"10.1016\/j.biopha.2019.108639","article-title":"The effect of Xinkeshu tablets on depression and anxiety symptoms in patients with coronary artery disease: Results from a double-blind, randomized, placebo-controlled study","volume":"112","author":"Ma","year":"2019","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1090","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3389\/fphar.2020.00600","article-title":"Investigation of the cellular pharmacological mechanism and clinical evidence of the multi-herbal antiarrhythmic Chinese Medicine Xin Su Ning","volume":"11","author":"Ma","year":"2020","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1095","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2017-04-569111","article-title":"Coagulation factor XII in thrombosis and inflammation","volume":"131","author":"Maas","year":"2018","journal-title":"Blood."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41573-020-0061-0","article-title":"Therapeutic strategies for thrombosis: New targets and approaches","volume":"19","author":"Mackman","year":"2020","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1105","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00394-018-1650-0","article-title":"Epicatechin's cardiovascular protective effects are mediated via opioid receptors and nitric oxide","volume":"58","author":"MacRae","year":"2019","journal-title":"European Journal of Nutrition"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1110","doi-asserted-by":"crossref","unstructured":"Mah, G. T., Tejani, A. M., & Musini, V. M. (2009) Methyldopa for primary hypertension. Cochrane Database of Systematic Reviews 2009, Cd003893.","DOI":"10.1002\/14651858.CD003893.pub3"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jnr.490320210","article-title":"Loss and recovery of activities of alpha+ and alpha isozymes of (Na(+) + K+)-ATPase in cortical focal ischemia: GM1 ganglioside protects plasma membrane structure and function","volume":"32","author":"Mahadik","year":"1992","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1120","doi-asserted-by":"crossref","first-page":"548","DOI":"10.34172\/aim.2020.58","article-title":"Effectiveness of polypill for prevention of cardiovascular disease (PolyPars): Protocol of a randomized controlled trial","volume":"23","author":"Malekzadeh","year":"2020","journal-title":"Archives of Iranian Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1125","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1742-1241.2010.02412.x","article-title":"A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy ('polypill') on cardiovascular risk factors","volume":"64","author":"Malekzadeh","year":"2010","journal-title":"International Journal of Clinical Practice"},{"key":"10.1016\/j.pharmthera.2020.107698_bb9415","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.drudis.2018.11.014","article-title":"Artificial intelligence in drug development: present status and future prospects","volume":"24","author":"Mak","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1130","doi-asserted-by":"crossref","DOI":"10.1016\/0002-9343(91)90274-2","article-title":"Ibopamine in the treatment of heart failure","volume":"90","author":"Man in't Veld, A.J","year":"1991","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1135","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/s12906-016-1406-4","article-title":"Traditional Chinese medicine, Danlou tablets alleviate adverse left ventricular remodeling after myocardial infarction: Results of a double-blind, randomized, placebo-controlled, pilot study","volume":"16","author":"Mao","year":"2016","journal-title":"BMC Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1140","first-page":"3","article-title":"Dietary anthocyanins for coronary artery disease: Berry good results","volume":"16","author":"Marcolina","year":"2013","journal-title":"Integrative Medicine Alert."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1145","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jacc.2017.11.019","article-title":"Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy","volume":"71","author":"Marwick","year":"2018","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1150","first-page":"864","article-title":"Epigallocatechin gallate, a potential immunomodulatory agent of tea components, diminishes cigarette smoke condensate-induced suppression of anti-Legionella pneumophila activity and cytokine responses of alveolar macrophages","volume":"9","author":"Matsunaga","year":"2002","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1155","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0006-291X(92)90792-J","article-title":"The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs","volume":"186","author":"Matter","year":"1992","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1160","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1039\/C5NP90043C","article-title":"Recognition of the role of natural products as drugs to treat neglected tropical diseases by the 2015 Nobel prize in physiology or medicine","volume":"32","author":"McKerrow","year":"2015","journal-title":"Natural Product Reports"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1165","first-page":"913","article-title":"Canadian cardiovascular society position statement--Recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease","volume":"22","author":"McPherson","year":"2006","journal-title":"The Canadian Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00003495-198938010-00003","article-title":"Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension","volume":"38","author":"McTavish","year":"1989","journal-title":"Drugs."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1175","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/VHRM.S3848","article-title":"Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction","volume":"5","author":"Melandri","year":"2009","journal-title":"Vascular Health and Risk Management"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1180","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(17)31071-1","article-title":"Heart failure","volume":"390","author":"Metra","year":"2017","journal-title":"The Lancet"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1185","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nature Reviews. Nephrology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1190","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.tips.2005.05.005","article-title":"Fundamental considerations of beta-adrenoceptor subtypes in human heart failure","volume":"26","author":"Molenaar","year":"2005","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1195","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0002-9149(03)00105-X","article-title":"Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study)","volume":"91","author":"Montalescot","year":"2003","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1200","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bjp.0702162","article-title":"The action of calcium channel blockers on recombinant L-type calcium channel alpha1-subunits","volume":"125","author":"Morel","year":"1998","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0735-1097(86)80251-0","article-title":"Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias","volume":"7","author":"Morganroth","year":"1986","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1210","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00007611-195704000-00015","article-title":"Deserpidine (canescine) for the treatment of hypertension","volume":"50","author":"Moyer","year":"1957","journal-title":"Southern Medical Journal"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1215","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2174\/187152509789105435","article-title":"Optimal management of hypertension in patients with ischemic heart disease","volume":"7","author":"Mukherjee","year":"2009","journal-title":"Cardiovascular & Hematological Agents in Medicinal Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107698_bb9411","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/pr.115.011247","article-title":"Pharmacology of Heparin and Related Drugs","volume":"68","author":"Barbara","year":"2016","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1220","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jbt.20369","article-title":"Thymoquinone supplementation attenuates cyclophosphamide-induced cardiotoxicity in rats","volume":"25","author":"Nagi","year":"2011","journal-title":"Journal of Biochemical and Molecular Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1225","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/np200906s","article-title":"Natural products as sources of new drugs over the 30 years from 1981 to 2010","volume":"75","author":"Newman","year":"2012","journal-title":"Journal of Natural Products"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1230","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"Journal of Natural Products"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1235","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/ALN.0000000000001880","article-title":"A random-allocation graded dose-response study of norepinephrine and phenylephrine for treating hypotension during spinal anesthesia for Cesarean delivery","volume":"127","author":"Ngan Kee","year":"2017","journal-title":"Anesthesiology."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1240","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1110874","article-title":"Effect of two intensive statin regimens on progression of coronary disease","volume":"365","author":"Nicholls","year":"2011","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1245","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2147\/IJGM.S22115","article-title":"Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus","volume":"4","author":"Nomura","year":"2011","journal-title":"International Journal of General Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1250","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1007\/s00380-018-1175-8","article-title":"Evaluation of the risk factors for ventricular arrhythmias secondary to QT prolongation induced by papaverine injection during coronary flow reserve studies using a 4 Fr angio-catheter","volume":"33","author":"Okabe","year":"2018","journal-title":"Heart and Vessels"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1255","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1536\/jhj.44.899","article-title":"Effects of enoxaparin and nadroparin on major cardiac events in high-risk unstable angina treated with a glycoprotein IIb\/IIIa inhibitor","volume":"44","author":"Okmen","year":"2003","journal-title":"Japanese Heart Journal"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1260","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0306-3623(96)00421-1","article-title":"Biological effects of myricetin","volume":"29","author":"Ong","year":"1997","journal-title":"General Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1265","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pharmthera.2018.01.001","article-title":"Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities","volume":"186","author":"Ong","year":"2018","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1270","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1389201015666141202110216","article-title":"Naringenin and atherosclerosis: A review of literature","volume":"16","author":"Orhan","year":"2015","journal-title":"Current Pharmaceutical Biotechnology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1275","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13059-019-1758-4","article-title":"Cytoscape automation: Empowering workflow-based network analysis","volume":"20","author":"Otasek","year":"2019","journal-title":"Genome Biology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1280","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/s41591-018-0089-4","article-title":"Verapamil and beta cell function in adults with recent-onset type 1 diabetes","volume":"24","author":"Ovalle","year":"2018","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1285","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/ejhf.1043","article-title":"Why is the use of digitalis withering? Another reason that we need medical heart failure specialists","volume":"20","author":"Packer","year":"2018","journal-title":"European Journal of Heart Failure"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1290","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.biopha.2017.11.151","article-title":"Oleanolic acid protects against pathogenesis of atherosclerosis, possibly via FXR-mediated angiotensin (Ang)-(1-7) upregulation","volume":"97","author":"Pan","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1295","doi-asserted-by":"crossref","first-page":"F209","DOI":"10.1152\/ajprenal.00252.2014","article-title":"Theobromine increases NAD+\/Sirt-1 activity and protects the kidney under diabetic conditions","volume":"308","author":"Papadimitriou","year":"2015","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1300","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/1076029609334125","article-title":"Pharmacokinetic characteristics of a vasodilatory and antiplatelet agent, limaprost alfadex, in the healthy Korean volunteers","volume":"16","author":"Park","year":"2010","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1305","doi-asserted-by":"crossref","first-page":"103400","DOI":"10.1016\/j.etap.2020.103400","article-title":"Digoxin: Pharmacology and toxicology-A review","volume":"79","author":"Patocka","year":"2020","journal-title":"Environmental Toxicology and Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1310","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.drudis.2015.01.009","article-title":"An analysis of FDA-approved drugs: natural products and their derivatives","volume":"21","author":"Patridge","year":"2016","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1315","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41569-019-0225-y","article-title":"Role of aspirin in primary prevention of cardiovascular disease","volume":"16","author":"Patrono","year":"2019","journal-title":"Nature Reviews. Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1320","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0735-1097(98)00279-4","article-title":"Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries","volume":"32","author":"Pfisterer","year":"1998","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1325","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/ehjcvp\/pvw016","article-title":"Mineralocorticoid receptor antagonists in patients with heart failure: Current experience and future perspectives","volume":"3","author":"Pitt","year":"2017","journal-title":"European Heart Journal Cardiovascular Pharmacotherpay"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107698_bb9409","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/sj.bjp.0704061","article-title":"Neuromodulatory effect of propentofylline on rat brain under acute and long-term hypoperfusion","volume":"133","author":"Plaschke","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1330","first-page":"554","article-title":"On the effect of adoniside on the blood circulation and respiration in the cat in acute insufficiency of the left ventricle of the heart","volume":"24","author":"Poliakov","year":"1961","journal-title":"Farmakologiia i Toksikologiia"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1335","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/FJC.0b013e3181af04e5","article-title":"Flaxseed and cardiovascular health","volume":"54","author":"Prasad","year":"2009","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1340","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1073\/pnas.1614680114","article-title":"Retrospective analysis of natural products provides insights for future discovery trends","volume":"114","author":"Pye","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1345","first-page":"223","article-title":"Anti-apoptotic effects and mechanisms of salvianolic acid A on cardiomyocytes in ischemia-reperfusion injury","volume":"34","author":"Qian","year":"2019","journal-title":"Histology and Histopathology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1350","doi-asserted-by":"crossref","first-page":"1716430","DOI":"10.1155\/2018\/1716430","article-title":"Efficacy and safety of zhenyuan capsule for coronary heart disease with abnormal glucose and lipid metabolism: Study protocol for a randomized, double-blind, parallel-controlled, multicenter clinical trial","volume":"2018","author":"Qiao","year":"2018","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1355","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pharmthera.2014.11.012","article-title":"Cardioprotective potential of annexin-A1 mimetics in myocardial infarction","volume":"148","author":"Qin","year":"2015","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1360","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1586\/ecp.09.41","article-title":"Antioxidants in the prevention of myocardial ischemia\/reperfusion injury","volume":"2","author":"Qin","year":"2009","journal-title":"Expert Review of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1365","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1021\/jm070352h","article-title":"Understanding the cardioprotective effects of flavonols: Discovery of relaxant flavonols without antioxidant activity","volume":"51","author":"Qin","year":"2008","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1370","doi-asserted-by":"crossref","first-page":"16615","DOI":"10.1038\/s41598-017-16317-1","article-title":"Endogenous Annexin-A1 regulates haematopoietic stem cell mobilisation and inflammatory response post myocardial infarction in mice in vivo","volume":"7","author":"Qin","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1375","doi-asserted-by":"crossref","first-page":"14232","DOI":"10.1038\/ncomms14232","article-title":"Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice","volume":"8","author":"Qin","year":"2017","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1380","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fphar.2019.00269","article-title":"Cardioprotective Actions of the Annexin-A1 N-Terminal Peptide, Ac(2-26), Against myocardial infarction","volume":"10","author":"Qin","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1385","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.freeradbiomed.2011.07.003","article-title":"Antioxidant activity contributes to flavonol cardioprotection during reperfusion of rat hearts","volume":"51","author":"Qin","year":"2011","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1390","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jnutbio.2012.09.006","article-title":"Malvidin, a red wine polyphenol, modulates mammalian myocardial and coronary performance and protects the heart against ischemia\/reperfusion injury","volume":"24","author":"Quintieri","year":"2013","journal-title":"The Journal of Nutritional Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1395","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0140-6736(19)30541-0","article-title":"The rise and fall of aspirin in the primary prevention of cardiovascular disease","volume":"393","author":"Raber","year":"2019","journal-title":"Lancet."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1400","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1177\/0960327119842620","article-title":"Ursolic acid modulates MMPs, collagen-I, \u03b1-SMA, and TGF-\u03b2 expression in isoproterenol-induced myocardial infarction in rats","volume":"38","author":"Radhiga","year":"2019","journal-title":"Human & Experimental Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1405","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/01.CIR.55.3.519","article-title":"Multiclinic controlled trial of bethanidine and guanethidine in severe hypertension","volume":"55","author":"Ramirez","year":"1977","journal-title":"Circulation."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1410","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2020.460903","article-title":"Profiling and structural analysis of cardenolides in two species of Digitalis using liquid chromatography coupled with high-resolution mass spectrometry","author":"Ravi","year":"2020","journal-title":"Journal of Chromatography. A"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1415","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.hlc.2020.01.001","article-title":"Cardiac rehabilitation and secondary prevention roundtable: Australian implementation and research priorities","volume":"29","author":"Redfern","year":"2020","journal-title":"Heart, Lung & Circulation"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1420","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.hipert.2017.12.005","article-title":"Resistant hypertension: An update","volume":"36","author":"Renna","year":"2019","journal-title":"Hipertens Riesgo Vascular"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1425","first-page":"896","article-title":"5'-adenosine monophosphate-activated protein kinase and lifestyle-mediated diseases","volume":"168","author":"Richter","year":"2006","journal-title":"Ugeskrift for Laeger"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1430","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.taap.2005.07.011","article-title":"The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stress","volume":"212","author":"Riganti","year":"2005","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1435","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.taap.2005.07.011","article-title":"The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stress","volume":"212","author":"Riganti","year":"2006","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1440","article-title":"An international randomised placebo-controlled trial of a four-component combination pill (\"polypill\") in people with raised cardiovascular risk","volume":"6","author":"Rodgers","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1445","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2174\/0929867322666141212122921","article-title":"Oleanolic acid and related triterpenoids from olives on vascular function: Molecular mechanisms and therapeutic perspectives","volume":"22","author":"Rodriguez-Rodriguez","year":"2015","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1450","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD012185","article-title":"Heparin for the treatment of thrombosis in neonates","volume":"11","author":"Romantsik","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1455","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/00004872-199715110-00019","article-title":"Clinical results of the Verapamil inHypertension and Atherosclerosis Study. VHAS Investigators","volume":"15","author":"Rosei","year":"1997","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1460","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0140-6736(19)31791-X","article-title":"Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): A pragmatic, cluster-randomised trial","volume":"394","author":"Roshandel","year":"2019","journal-title":"Lancet."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1465","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S0140-6736(18)31808-7","article-title":"Heart failure drug treatment","volume":"393","author":"Rossignol","year":"2019","journal-title":"Lancet."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1470","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11886-017-0853-y","article-title":"Strengths and limitations of using the polypill in cardiovascular prevention","volume":"19","author":"Roy","year":"2017","journal-title":"Current Cardiology Reports"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1475","first-page":"612","article-title":"Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke","volume":"13","author":"Sacks","year":"2018","journal-title":"International Journal of Stroke"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1480","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.phrs.2018.03.009","article-title":"Curcumin in heart failure: A choice for complementary therapy?","volume":"131","author":"Saeidinia","year":"2018","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1485","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ijcard.2008.11.041","volume":"140","author":"Sakuma","year":"2010","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1490","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.preghy.2019.05.009","article-title":"Methyldopa versus nifedipine or no medication for treatment of chronic hypertension during pregnancy: A multicenter randomized clinical trial","volume":"17","author":"Salama","year":"2019","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1495","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bbrc.2010.03.050","article-title":"Celastrol: Molecular targets of thunder god vine","volume":"394","author":"Salminen","year":"2010","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1500","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1081\/CEH-100100081","article-title":"The effect of docarpamine, a dopamine pro-drug, on blood pressure and catecholamine levels in spontaneously hypertensive rats","volume":"22","author":"Sanada","year":"2000","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1505","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.1957.02980070025005","article-title":"Acetyldigitoxin in therapy of ambulatory patients with congestive heart failure","volume":"164","author":"Sanazaro","year":"1957","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1510","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1002\/jcb.27522","article-title":"Berbamine ameliorates isoproterenol-induced myocardial infarction by inhibiting mitochondrial dysfunction and apoptosis in rats","volume":"120","author":"Saranya","year":"2019","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1515","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13063-018-2564-0","article-title":"Stroke minimization through additive anti-atherosclerotic agents in routine treatment (SMAART): Study protocol for a randomized controlled trial","volume":"19","author":"Sarfo","year":"2018","journal-title":"Trials."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1520","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.metabol.2006.01.016","article-title":"An alpha-glucosidase inhibitor, voglibose, reduces oxidative stress markers and soluble intercellular adhesion molecule 1 in obese type 2 diabetic patients","volume":"55","author":"Satoh","year":"2006","journal-title":"Metabolism."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1525","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.yjmcc.2016.08.003","article-title":"Leoligin, the major lignan from Edelweiss, inhibits 3-hydroxy-3-methyl-glutaryl-CoA reductase and reduces cholesterol levels in ApoE-\/- mice","volume":"99","author":"Scharinger","year":"2016","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1530","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/BF00788878","article-title":"Reduced 3H-ouabain binding site (Na,K-ATPase) concentration in ventricular myocardium of dogs with tachycardia induced heart failure","volume":"88","author":"Schmidt","year":"1993","journal-title":"Basic Research in Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1535","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0021-9258(18)54110-7","article-title":"Reserpine binding to a vesicular amine transporter expressed in Chinese hamster ovary fibroblasts","volume":"268","author":"Schuldiner","year":"1993","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1540","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng.784","article-title":"Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease","volume":"43","author":"Schunkert","year":"2011","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1545","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/heartjnl-2018-313108","article-title":"Reaching cardiovascular prevention guideline targets with a polypill-based approach: A meta-analysis of randomised clinical trials","volume":"105","author":"Selak","year":"2019","journal-title":"Heart."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1550","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1532-5415.1961.tb02508.x","article-title":"An evaluation of combined benzthiazide and rescinnamine therapy in arterial hypertension","volume":"9","author":"Settel","year":"1961","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1555","article-title":"Blood pressure-lowering efficacy of reserpine for primary hypertension","volume":"12","author":"Shamon","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1560","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fphar.2019.00025","article-title":"The genus adonis as an important cardiac folk medicine: A review of the ethnobotany, Phytochemistry and Pharmacology","volume":"10","author":"Shang","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1565","doi-asserted-by":"crossref","first-page":"9173436","DOI":"10.1155\/2018\/9173436","article-title":"Fisetin confers cardioprotection against myocardial ischemia reperfusion injury by suppressing mitochondrial oxidative stress and mitochondrial dysfunction and inhibiting glycogen synthase kinase 3\u03b2 activity","volume":"2018","author":"Shanmugam","year":"2018","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1570","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12192-014-0536-1","article-title":"Celastrol, an oral heat shock activator, ameliorates multiple animal disease models of cell death","volume":"20","author":"Sharma","year":"2015","journal-title":"Cell Stress & Chaperones"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1575","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jep.2014.09.035","article-title":"Shensong Yangxin Capsule prevents diabetic myocardial fibrosis by inhibiting TGF-\u03b21\/Smad signaling","volume":"157","author":"Shen","year":"2014","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1580","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ijbiomac.2018.11.190","article-title":"Involvement of Nrf2 in myocardial ischemia and reperfusion injury","volume":"125","author":"Shen","year":"2019","journal-title":"International Journal of Biological Macromolecules"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1585","doi-asserted-by":"crossref","DOI":"10.1177\/1559325820912067","article-title":"Activation of CREB protein with tabersonine attenuates STAT3 during atherosclerosis in apolipoprotein E-deficient mice","volume":"18","author":"Shi","year":"2020","journal-title":"Dose-Response"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1590","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1096\/fj.12-223008","article-title":"Hyodeoxycholic acid improves HDL function and inhibits atherosclerotic lesion formation in LDLR-knockout mice","volume":"27","author":"Shih","year":"2013","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1595","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3109\/21691401.2015.1052472","article-title":"Development, optimization, and characterization of polymeric electrospun nanofiber: A new attempt in sublingual delivery of nicorandil for the management of angina pectoris","volume":"44","author":"Singh","year":"2015","journal-title":"Artificial Cells Nanomedicine Biotechnology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1600","first-page":"E6271","article-title":"Statistical reanalysis of natural products reveals increasing chemical diversity","volume":"114","author":"Skinnider","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1605","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bbrc.2012.09.061","article-title":"Piperlongumine inhibits atherosclerotic plaque formation and vascular smooth muscle cell proliferation by suppressing PDGF receptor signaling","volume":"427","author":"Son","year":"2012","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1610","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/10739680701833804","article-title":"Prostacyclin analogs stimulate receptor-mediated cAMP synthesis and ATP release from rabbit and human erythrocytes","volume":"15","author":"Sprague","year":"2008","journal-title":"Microcirculation."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1615","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1745-6215-12-13","article-title":"Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): A randomized placebo-controlled phase-2 dose-finding study of rostafuroxin","volume":"12","author":"Staessen","year":"2011","journal-title":"Trials."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1620","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrcardio.2009.33","article-title":"Prevention of venous thromboembolism in medical patients and outpatients","volume":"6","author":"Stashenko","year":"2009","journal-title":"Nature Reviews. Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1625","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1164\/ajrccm.185.9.1028","article-title":"Potentially fatal arrhythmia complicating endobronchial epinephrine for control of iatrogenic bleeding","volume":"185","author":"Steinfort","year":"2012","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1630","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1113\/jphysiol.2007.128785","article-title":"Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+\/- murine hearts modelling the Brugada syndrome","volume":"581","author":"Stokoe","year":"2007","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1635","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40261-017-0600-6","article-title":"Comparison of once-daily bemiparin with twice-daily enoxaparin for acute deep vein thrombosis: A multicenter, open-label. Randomized Controlled Trial","volume":"38","author":"Suchkov","year":"2017","journal-title":"Clinical Drug Investigation"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1640","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cbi.2017.02.012","article-title":"Hypotensive effects of genistein: From chemistry to medicine","volume":"268","author":"Sureda","year":"2017","journal-title":"Chemico-Biological Interactions"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1645","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/jama.2015.517","article-title":"Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction","volume":"313","author":"Szummer","year":"2015","journal-title":"Jama."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1650","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1093\/eurheartj\/ehz435","article-title":"Predicting cardiac electrical response to sodium-channel blockade and Brugada syndrome using polygenic risk scores","volume":"40","author":"Tadros","year":"2019","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1655","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/cvr\/cvp264","article-title":"Targeting calcium transport in ischaemic heart disease","volume":"84","author":"Talukder","year":"2009","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1660","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1021\/acs.chemrev.6b00478","article-title":"Oxidative cyclization in natural product biosynthesis","volume":"117","author":"Tang","year":"2017","journal-title":"Chemical Reviews"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1665","doi-asserted-by":"crossref","first-page":"537014","DOI":"10.1155\/2014\/537014","article-title":"The comparative study on expression of SIRT1 signal transduction by Xuefuzhuyu Capsule","volume":"2014","author":"Teng","year":"2014","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1670","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11906-010-0127-1","article-title":"Polypill: Lights and shadows","volume":"12","author":"Teo","year":"2010","journal-title":"Current Hypertension Reports"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1675","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/2047487312463278","article-title":"Use of a multidrug pill in reducing cardiovascular events (UMPIRE): Rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in India and Europe","volume":"21","author":"Thom","year":"2014","journal-title":"European Journal of Preventive Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1680","doi-asserted-by":"crossref","first-page":"E018052","DOI":"10.1136\/bmjopen-2017-018052","article-title":"Efficacy and safety of the Shexiang Baoxin Pill for the treatment of coronary artery disease not amenable to revascularisation: Study protocol for a randomised, placebo-controlled, double-blinded trial","volume":"8","author":"Tian","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1685","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bbrc.2018.02.121","article-title":"Celastrol pretreatment attenuates rat myocardial ischemia\/ reperfusion injury by inhibiting high mobility group box 1 protein expression via the PI3K\/Akt pathway","volume":"497","author":"Tong","year":"2018","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1690","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1093\/eurheartj\/ehw334","article-title":"Cardiovascular disease in Europe: Epidemiological update 2016","volume":"37","author":"Townsend","year":"2016","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1695","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1111\/bph.13944","article-title":"Therapeutic concentrations of digitoxin inhibit endothelial focal adhesion kinase and angiogenesis induced by different growth factors","volume":"174","author":"Trenti","year":"2017","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1700","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jacc.2016.10.055","article-title":"Cangrelor with and without glycoprotein IIb\/IIIa Inhibitors in patients undergoing percutaneous coronary intervention","volume":"69","author":"Vaduganathan","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1705","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1161\/ATVBAHA.113.301988","article-title":"Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling","volume":"33","author":"Vaiyapuri","year":"2013","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1710","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/eurheartj\/ehv143","article-title":"Digoxin-associated mortality: A systematic review and meta-analysis of the literature","volume":"36","author":"Vamos","year":"2015","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1715","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","article-title":"The mechanism of action of aspirin","volume":"110","author":"Vane","year":"2003","journal-title":"Thrombosis Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1720","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/ejhf.1200","article-title":"Value of digoxin in patients with heart failure: New pieces to the puzzle","volume":"20","author":"van Veldhuisen","year":"2018","journal-title":"European Journal of Heart Failure"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1725","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2174\/092986707780831078","article-title":"Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: A review","volume":"14","author":"Venardos","year":"2007","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1730","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2165\/00003495-197713030-00002","article-title":"Clinical use of verapamil","volume":"13","author":"Vohra","year":"1977","journal-title":"Drugs."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1735","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: A systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Vos","year":"2016","journal-title":"The Lancet."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1740","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10741-018-9676-1","article-title":"Protein tyrosine phosphatases in cardiac physiology and pathophysiology","volume":"23","author":"Wade","year":"2018","journal-title":"Heart Failure Reviews"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1745","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.2174\/0929867324666170605091546","article-title":"Snake venom: From deadly toxins to life-saving therapeutics","volume":"24","author":"Waheed","year":"2017","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1750","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041297","article-title":"Randomized polypill crossover trial in people aged 50 and over","volume":"7","author":"Wald","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1755","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejphar.2019.05.003","article-title":"Protocatechualdehyde reduces myocardial fibrosis by directly targeting conformational dynamics of collagen","volume":"855","author":"Wan","year":"2019","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1760","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/jcmm.13111","article-title":"Qiliqiangxin protects against anoxic injury in cardiac microvascular endothelial cells via NRG-1\/ErbB-PI3K\/Akt\/mTOR pathway","volume":"21","author":"Wang","year":"2017","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1765","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3177\/jnsv.65.470","article-title":"The protective effects of myricetin against cardiovascular disease","volume":"65","author":"Wang","year":"2019","journal-title":"Journal of Nutritional Science and Vitaminology (Tokyo)"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1770","first-page":"115","article-title":"Developmental neurotoxicity of reserpine exposure in zebrafish larvae (Danio rerio)","volume":"223","author":"Wang","year":"2019","journal-title":"Comparative Biochemistry and Physiology, Part C: Toxicology & Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1775","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejphar.2009.10.001","article-title":"3',4'-Dihydroxyflavonol improves post-ischaemic coronary endothelial function following 7days reperfusion in sheep","volume":"624","author":"Wang","year":"2009","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1780","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3109\/13880209.2014.986688","article-title":"Chrysin inhibits foam cell formation through promoting cholesterol efflux from RAW264.7 macrophages","volume":"53","author":"Wang","year":"2015","journal-title":"Pharmaceutical Biology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1785","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fphar.2019.00070","article-title":"Ion channel targeted mechanisms of anti-arrhythmic Chinese Herbal Medicine Xin Su Ning","volume":"10","author":"Wang","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1790","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neures.2014.01.005","article-title":"Ecdysterone protects gerbil brain from temporal global cerebral ischemia\/reperfusion injury via preventing neuron apoptosis and deactivating astrocytes and microglia cells","volume":"81-82","author":"Wang","year":"2014","journal-title":"Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1795","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.4103\/0366-6999.209906","article-title":"Effects of traditional Chinese Medicine Shensong Yangxin capsules on heart rhythm and function in congestive heart failure patients with frequent ventricular premature complexes: A Randomized, double-blind. multicenter clinical trial","volume":"130","author":"Wang","year":"2017","journal-title":"Chinese Medical Journal"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1800","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.biopha.2017.11.032","article-title":"Ursolic acid ameliorates oxidative stress, inflammation and fibrosis in diabetic cardiomyopathy rats","volume":"97","author":"Wang","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1805","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3892\/etm.2012.766","article-title":"Honokiol protects rat hearts against myocardial ischemia reperfusion injury by reducing oxidative stress and inflammation","volume":"5","author":"Wang","year":"2013","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1810","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2174\/1566524019666190207143207","article-title":"Naoxintong retards atherosclerosis by inhibiting foam cell formation through activating ppar\u03b1 pathway","volume":"18","author":"Wang","year":"2018","journal-title":"Current Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1815","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1093\/ajh\/7.10.146S","article-title":"Coronary heart disease and hypertension","volume":"7","author":"Weber","year":"1994","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1820","doi-asserted-by":"crossref","first-page":"676","DOI":"10.7326\/0003-4819-121-9-199411010-00009","article-title":"Interactions of warfarin with drugs and food","volume":"121","author":"Wells","year":"1994","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1825","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","article-title":"Global burden of thrombosis: Epidemiologic aspects","volume":"118","author":"Wendelboe","year":"2016","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1830","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.bjp.0705446","article-title":"Pharmacokinetic study on the utilisation of 5-methyltetrahydrofolate and folic acid in patients with coronary artery disease","volume":"141","author":"Willems","year":"2004","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1835","article-title":"BSN723T prevents atherosclerosis and weight gain in ApoE Knockout Mice Fed a Western Diet","volume":"6","author":"Williams","year":"2015","journal-title":"Webmedcentral."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1840","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.2174\/0929867325666180326161730","article-title":"Flavonols and flavones - Protecting against myocardial ischemia\/reperfusion injury by targeting protein kinases","volume":"25","author":"Woodman","year":"2018","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1845","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.phrs.2014.01.004","article-title":"The cardioprotectant 3',4'-dihydroxyflavonol inhibits opening of the mitochondrial permeability transition pore after myocardial ischemia and reperfusion in rats","volume":"81","author":"Woodman","year":"2014","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1850","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.hrthm.2008.09.008","article-title":"Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine","volume":"5","author":"Wu","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1855","doi-asserted-by":"crossref","first-page":"10358","DOI":"10.1002\/jcb.27379","article-title":"Piperlongumine inhibits angiotensin II-induced extracellular matrix expression in cardiac fibroblasts","volume":"119","author":"Wu","year":"2018","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1860","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejphar.2019.03.021","article-title":"Tanshinone I inhibits vascular smooth muscle cell proliferation by targeting insulin-like growth factor-1 receptor\/phosphatidylinositol-3-kinase signaling pathway","volume":"853","author":"Wu","year":"2019","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1865","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejphar.2018.07.004","article-title":"Notoginsenoside R1, a unique constituent of Panax notoginseng, blinds proinflammatory monocytes to protect against cardiac hypertrophy in ApoE(-\/-) mice","volume":"833","author":"Xiao","year":"2018","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1870","first-page":"357","article-title":"Integrative pharmacology:new paradigm of modernization of Chinese medicine","volume":"39","author":"Xu","year":"2014","journal-title":"China Journal of Chinese Materia Medica."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1875","doi-asserted-by":"crossref","first-page":"D976","DOI":"10.1093\/nar\/gky987","article-title":"ETCM: An encyclopaedia of traditional Chinese medicine","volume":"47","author":"Xu","year":"2019","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1880","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/cjoc.201200201","article-title":"Identification and synthesis of impurities in Pinocembrin\u2013A New drug for the treatment of ischemic stroke","volume":"30","author":"Yang","year":"2012","journal-title":"Chinese Journal of Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1885","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.phymed.2018.04.042","article-title":"Cardioprotective role of azafrin in against myocardial injury in rats via activation of the Nrf2-ARE pathway","volume":"47","author":"Yang","year":"2018","journal-title":"Phytomedicine."},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107698_bb9412","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1002\/bit.27332","article-title":"Systems metabolic engineering of Bacillus subtilis for efficient biosynthesis of 5-methyltetrahydrofolate","volume":"117","author":"Yang","year":"2020","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1890","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12906-020-2821-0","article-title":"Study protocol for a randomized controlled trial: Qiliqiangxin in heart failUre: assESsment of reduction in morTality (QUEST)","volume":"20","author":"Yao","year":"2020","journal-title":"BMC Complementary Medicine and Therapies"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1895","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1159\/000366349","article-title":"Tetrahydroxystilbene glucoside protects against oxidized LDL-induced endothelial dysfunction via regulating vimentin cytoskeleton and its colocalization with ICAM-1 and VCAM-1","volume":"34","author":"Yao","year":"2014","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1900","doi-asserted-by":"crossref","first-page":"17981","DOI":"10.1038\/s41598-017-18069-4","article-title":"Proteomic investigation of effects of hydroxysafflor yellow A in oxidized low-density lipoprotein-induced endothelial injury","volume":"7","author":"Ye","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1905","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1532-5415.2007.01230.x","article-title":"Effect of xuezhikang on cardiovascular events and mortality in elderly patients with a history of myocardial infarction: A subgroup analysis of elderly subjects from the China Coronary Secondary Prevention Study","volume":"55","author":"Ye","year":"2007","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1910","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ejphar.2017.08.035","article-title":"Danshensu accelerates angiogenesis after myocardial infarction in rats and promotes the functions of endothelial progenitor cells through SDF-1\u03b1\/CXCR4 axis","volume":"814","author":"Yin","year":"2017","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1915","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s10753-011-9400-y","article-title":"Pyranocoumarins Isolated from peucedanum praeruptorum dunn suppress lipopolysaccharide-induced inflammatory response in murine macrophages through inhibition of NF-\u03baB and STAT3 activation","volume":"35","author":"Yu","year":"2012","journal-title":"Inflammation."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1920","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3892\/mmr.2015.4660","article-title":"Honokiol protects against renal ischemia\/reperfusion injury via the suppression of oxidative stress, iNOS, inflammation and STAT3 in rats","volume":"13","author":"Yu","year":"2016","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1925","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(09)60611-5","article-title":"Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): A phase II, double-blind, randomised trial","volume":"373","author":"Yusuf","year":"2009","journal-title":"Lancet."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1930","doi-asserted-by":"crossref","first-page":"13867","DOI":"10.1038\/s41598-017-10131-5","article-title":"Screening and identification of critical transcription factors involved in the protection of cardiomyocytes against hydrogen peroxide-induced damage by Yixin-shu","volume":"7","author":"Zhang","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1935","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2009.01.046","article-title":"Salidroside protects cardiomyocyte against hypoxia-induced death: A HIF-1alpha-activated and VEGF-mediated pathway","volume":"607","author":"Zhang","year":"2009","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1940","first-page":"4951820","article-title":"Huangbai Liniment accelerated wound healing by activating Nrf2 signaling in diabetes","volume":"2020a","author":"Zhang","year":"2020","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1945","first-page":"4951820","article-title":"Huangbai Liniment accelerated wound healing by activating Nrf2 signaling in diabetes","volume":"2020b","author":"Zhang","year":"2020","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1950","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4103\/0366-6999.226064","article-title":"A multicenter, randomized, double-blind, and placebo-controlled study of the effects of Tongxinluo capsules in acute coronary syndrome patients with high on-treatment platelet reactivity","volume":"131","author":"Zhang","year":"2018","journal-title":"Chinese Medical Journal"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1955","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1038\/s41598-019-41118-z","article-title":"Carotid artery plaque intervention with Tongxinluo capsule (CAPITAL): A multicenter randomized double-blind parallel-group placebo-controlled study","volume":"9","author":"Zhang","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1960","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s10787-017-0429-x","article-title":"(-)-Epigallocatechin-3-gallate, the major green tea catechin, regulates the desensitization of \u03b21 adrenoceptor via GRK2 in experimental heart failure","volume":"26","author":"Zhang","year":"2018","journal-title":"Inflammopharmacology."},{"key":"10.1016\/j.pharmthera.2020.107698_bb1965","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1073\/pnas.0813142106","article-title":"A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR\/ABL-associated leukemia","volume":"106","author":"Zhang","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1970","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm.4017","article-title":"CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis","volume":"22","author":"Zhang","year":"2016","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1975","first-page":"1941","article-title":"Study on the application of intestinal absorption in vitro coupled with bioactivity assessment in Yuanhu Zhitong preparation","volume":"6","author":"Zhang","year":"2012","journal-title":"Journal of Medicinal Plant Research"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1980","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/aps.2017.117","article-title":"Main active constituent identification in Guanxinjing capsule, a traditional Chinese medicine, for the treatment of coronary heart disease complicated with depression","volume":"39","author":"Zhang","year":"2018","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1985","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41569-018-0119-4","article-title":"Epidemiology of cardiovascular disease in China: Current features and implications","volume":"16","author":"Zhao","year":"2019","journal-title":"Nature Reviews. Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1990","doi-asserted-by":"crossref","first-page":"E16539","DOI":"10.1097\/MD.0000000000016539","article-title":"Efficacy and safety of Xinnaoning capsule in treating chronic stable angina (qi stagnation and blood stasis syndrome): Study protocol for a multicenter, randomized, double-blind, placebo-controlled trial","volume":"98","author":"Zhao","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.pharmthera.2020.107698_bb1995","doi-asserted-by":"crossref","first-page":"8485472","DOI":"10.1155\/2018\/8485472","article-title":"Treatment of Danhong injection combined with naoxintong capsule in acute coronary syndrome patients undergoing PCI Operation: Study for a randomized controlled and double-blind trial","volume":"2018","author":"Zhao","year":"2018","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb2000","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/FJC.0b013e31802d3a58","article-title":"Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: Subgroup analysis of patients with type 2 diabetes from China coronary secondary prevention study (CCSPS)","volume":"49","author":"Zhao","year":"2007","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107698_bb2005","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.7","article-title":"Berbamine postconditioning protects the heart from ischemia\/reperfusion injury through modulation of autophagy","volume":"8","author":"Zheng","year":"2017","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2020.107698_bb2010","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s12192-019-01027-6","article-title":"Tanshinone IIA attenuates cardiac microvascular ischemia-reperfusion injury via regulating the SIRT1-PGC1\u03b1-mitochondrial apoptosis pathway","volume":"24","author":"Zhong","year":"2019","journal-title":"Cell Stress & Chaperones"},{"key":"10.1016\/j.pharmthera.2020.107698_bb2015","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.foodchem.2012.02.172","article-title":"Anti-inflammatory activity of lipophilic epigallocatechin gallate (EGCG) derivatives in LPS-stimulated murine macrophages","volume":"134","author":"Zhong","year":"2012","journal-title":"Food Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107698_bb2020","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2147\/DDDT.S160776","article-title":"Pharmacological activities, mechanisms of action, and safety of salidroside in the central nervous system","volume":"12","author":"Zhong","year":"2018","journal-title":"Drug Design, Development and Therapy"},{"key":"10.1016\/j.pharmthera.2020.107698_bb2025","first-page":"405","article-title":"Hydroxysafflor Yellow A mitigated myocardial ischemia\/reperfusion injury by inhibiting the activation of the JAK2\/STAT1 pathway","volume":"44","author":"Zhou","year":"2019","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2020.107698_bb2030","doi-asserted-by":"crossref","first-page":"12943","DOI":"10.1073\/pnas.1107336108","article-title":"Clustered patterns of species origins of nature-derived drugs and clues for future bioprospecting","volume":"108","author":"Zhu","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107698_bb2035","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.acthis.2013.11.005","article-title":"Honokiol suppresses TNF-\u03b1-induced migration and matrix metalloproteinase expression by blocking NF-\u03baB activation via the ERK signaling pathway in rat aortic smooth muscle cells","volume":"116","author":"Zhu","year":"2014","journal-title":"Acta Histochemica"},{"key":"10.1016\/j.pharmthera.2020.107698_bb2040","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1373\/clinchem.2006.078139","article-title":"Estimation of warfarin maintenance dose based on VKORC1 (-1639 G>A) and CYP2C9 genotypes","volume":"53","author":"Zhu","year":"2007","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107698_bb2045","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","article-title":"Epidemiology and aetiology of heart failure","volume":"13","author":"Ziaeian","year":"2016","journal-title":"Nature Reviews. Cardiology"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372582030228X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372582030228X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:13:36Z","timestamp":1759011216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016372582030228X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":412,"alternative-id":["S016372582030228X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107698","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current state and future perspective of cardiovascular medicines derived from natural products","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107698"}}